Atlas Trials

Phase 1 Study to Evaluate MEDI4736 in Subjects With Myelodysplastic Syndrome

Clinical trial NCT02117219 · COMPLETED

Trial details

NCT number
NCT02117219
Sponsor
MedImmune LLC
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Myelodysplastic Syndrome
Start date
2014-05-20
Primary completion
2019-04-30
Enrollment
67

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.